Most Popular Brands: Avonex, Avonex Prefilled Syringe
Generic Name: Interferon beta-1a IM Injection
Interferon beta-1a is a drug in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells while Interferon beta-1b is produced in modified E. coli. Interferons have been shown to have about a 30–35% reduction in the rate of MS relapses, and to slow the progression of disability in MS patients.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my MS progress | 1305 |
|
|
|
|
|
292 |
| Other | 53 |
|
|
|
|
10 | |
| General health | 19 |
|
|
|
|
5 | |
| Multiple Sclerosis (MS) | 14 |
|
|
3 | |||
| Fatigue | 11 |
|
1 | ||||
| Don't know | 10 |
|
3 |
See all 1013 patients currently taking Interferon beta-1a IM Injection
Mouse over the table for more information
Top 10 dosages based on patients currently taking Interferon beta-1a IM Injection. See all 57 dosages ►
| 300mcg as needed | daily | weekly | 0.05 mcg weekly | 0.25 mg weekly | 0.25 mL weekly | 0.325 mcg weekly | 0.5 mcg weekly | 0.5 mg weekly | 0.5 ml weekly | 0.5 mL weekly | 0.5 weekly | 1 mcg weekly | 1 mg weekly | 1 mL weekly | 1 other weekly | 1 weekly | 1.5 mcg weekly | 1.5 mg weekly | 4 weekly | 5 mcg weekly | 30 mcg monthly | 30 mcg/0.5 mL weekly | 10 mg weekly | 13.2 mg weekly | 2 mcg daily | 15 mcg weekly | 15 mg weekly | 30 mcg every other week | 33 mcg every other week | 20 mcg weekly | 22 mcg/0.5 mL weekly | 24 mcg weekly | 30 mcg/0.5 mL weekly | 30 mcg weekly | 30 mg weekly | 30 mmol/L weekly | 30 weekly | 33 mcg weekly | 35 mcg weekly | 37 mcg weekly | 44 mcg/0.5 mL weekly | 44 mg weekly | 50 mcg weekly | 50 mg weekly | 60 mcg weekly | 3 x 22 mcg/0.5 mL weekly | 80 mg weekly | 100 mcg weekly | 125 mcg weekly | 3 x 44 mcg/0.5 mL weekly | 200 mcg weekly | 30 mcg/0.5 mL daily | 30 mcg daily | 30.1 mcg daily | 44 mcg/0.5 mL daily | 360 mg weekly | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
170
|
1
|
2
|
1
|
1
|
6
|
2
|
1
|
1
|
2
|
18
|
10
|
4
|
3
|
10
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
1
|
227
|
389
|
25
|
1
|
10
|
3
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
7
|
29
|
21
|
1
|
2
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
288 | 41% |
|
|
Did not seem to work
|
244 | 35% |
|
|
Doctor's advice
|
214 | 31% |
|
|
Other
|
124 | 18% |
|
|
Expense
|
28 | 4% |
|
|
Personal research
|
21 | 3% |
|
|
Not indicated
|
10 | 1% |
|
|
Course of treatment ended
|
8 | 1% |
|
See all 665 patients who’ve stopped taking Interferon beta-1a IM Injection
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.